ONCO.IO

ONCO.IO is an integrative resource for microrna and transcription factors analysis in cancer.

Network analysis tools Build network by filter

* we are migrate to a new server (again..)



Database is updated every day (?)
last update: MIR98=>MAP4K3, 2019-10-05 12:38:50 by rhizoman1

ONCO.IO statistics

Total number of interactions:
16500

binding of miRNA:
6499

transcription regulation:
4612

drug interactions:
454

chemo/drugresistance:
211


metabolic reactions:
8244

TF => ncRNA reactions:
745

drug => gene/miR reactions:
454


Path. processes associations:
15568

Diseases associations:
9599

Pubmeds:
18318

Express.levels associations:
4092

Prognosis associations:
1954

Diagnosis associations:
52

Biomarker localization:
5300

Cell lines associations:
18161

Tumor stage associations:
55

Methods associations:
50908

Cell Localization:
413

number of new added interactions:
for last week:
0
(
+0
)
for last 2 weeks:
0

for last month:
0 (
-9
)

for last two month:
9

graph view


top annotators of last month:

ONCO.IO is an integrated knowledge database and network analysis tool for exploring complex gene regulatory networks involved in cancer.

ONCO.IO database content is based on the manually curated annotation of experimentally verified molecular interactions described in the literature and includes microRNAs, lncRNAs, mRNAs, signaling proteins and transcription factors interactions.

Key features:



Search term and build network:


Processes

Pathogenic process (PP) - molecular, cellular or tissue malfunction determining initiation, development and outcome of disease. Full list of PP is here
Interactions (or edges) are associated with pathogenic process and can influence as positively and negatively on the process.

Processes:

Diseases

Diseases:

Genes and ncRNAs

Symbol:



News:

Moscow Cancer Center Employees Threaten to Quit as Doctor Resignation Wave Hits Capital 03 October 2019 16:50:10 by Sasha Fokin
Doctors from the Research Institute of Pediatric Oncology and Hematology of the Blokhin National Medical Research Center for Oncology demanded a change of leadership. In a statement on the Doctors Alliance’s YouTube channel, they said they would quit otherwise.

Doctors complained of poor conditions for patients: lack of ventilation and mold in crowded rooms. Management, they said, instead of economic issues is engaged in "hardware struggle."

Another reason for writing applications was the dismissal of Georgy Mentkevich, the creator of the country's first bone marrow transplant department. Other specialists were forced to quit along with him.

At least 26 childrens oncologists at the Blokhin Cancer Center have threatened to quit if its recently appointed leader isnt fired, pay transparency isnt introduced and overcrowded and mold-covered wards arent replaced.


Thanks to our visitors! 26 July 2019 16:25:13 by Sasha Fokin
We thank the anonymous guest for pointing out the vulnerabilities. They are was patched, but there is still much to be done, and we are gradually completing it. While the project is running in the background.

miRs in prostate cancer: comlex regulatory connections with cancer hallmarks 18 January 2019 23:53:17 by Rhizoman1
Next week we will annotate regulatory interactions in prostate cancer. Prostate cancer (PCa) is considered the most prevalent malignancy and the second major cause of cancer-related death in males from Western countries. Androgen deprivation therapy (ADT) is the primary treatment option for male patients with advanced symptomatic PCa. Castration-resistant prostate cancer (CRPC) refers to the continuous progression of PCa following ADT. We will focus on the role of non-coding RNAs and transcription factors in prostate cancer development and progression.

Paywall: The Business of Scholarship 26 December 2018 16:17:32 by Sasha Fokin
Paywall: The Business of Scholarship is a documentary which focuses on the need for open access to research and science, questions the rationale behind the $25.2 billion a year that flows into for-profit academic publishers, examines the 35-40% profit margin associated with the top academic publisher Elsevier and looks at how that profit margin is often greater than some of the most profitable tech companies like Apple, Facebook and Google.

Paywall: The Business of Scholarship (Full Movie) CC BY 4.0 from Paywall The Movie on Vimeo.


The program of reduce the critical dependence of Russian science on foreign genetic and biological databases. 26 December 2018 16:10:04 by Sasha Fokin
"The Ministry of Education and Science proposes to allocate 220.5 billion rubles. on the development of genetic technologies in the framework of the federal scientific and technical program for the years 2019-2027. This is stated in the draft government decree on the approval of the program, published on Friday on the federal portal of draft regulations. The implementation of the program is designed to "reduce the critical dependence of Russian science on foreign genetic and biological data bases, foreign specialized software and devices, the programs passport says. In Russia, bioinformatics and genetic databases, basic reagents and software products and equipment prototypes should be created." The leading scientific organization will be the Kurchatov Institute. The ONCO.IO is made entirely by our forces and means without the help of any other structures and organizations. This is a completely independent product. For all inhabitants of the planet Earth, we provide equal access to ONCO.IO and his services.

Immune response interactome! 06 October 2018 01:24:29 by Rhizoman1
T-cell-DC, signaling and regulatory pathways that develop immune response. Co-regulatory and repressor molecules. Receptors, signaling molecules, transcription factors as are drivers of anti-cancer immunity. Next week we will annotate immunoregulatory interactome! This is dedicated to the Nobel prize in Physiology or Medicine 2018!

Hooray! Today our database reached the milestone of 15,000 manualy curated validated links 27 September 2018 15:33:44 by Sasha Fokin




Blog

Last saved networks:

network_1573561931 [12 November 2019 16:32:11 by guest ]
test1_5 [08 November 2019 14:59:01 by guest ]
test1_43 [08 November 2019 14:57:02 by guest ]
test1_2 [08 November 2019 14:40:03 by guest ]
test1_123 [08 November 2019 14:37:05 by guest ]
test1_12 [08 November 2019 14:35:31 by guest ]
test1_1 [08 November 2019 14:32:24 by guest ]
test1_1 [08 November 2019 14:30:26 by guest ]
test1 [08 November 2019 14:30:14 by guest ]
hh [07 November 2019 22:20:22 by guest ]
lnc-mrna [07 November 2019 21:55:24 by guest ]
lnc-mrna [07 November 2019 21:55:02 by guest ]
lnc-mrna [07 November 2019 21:54:56 by guest ]
qq [28 October 2019 15:23:10 by guest ]
RELA [26 September 2019 14:19:26 by guest ]
mir488 [16 September 2019 22:18:44 by guest ]
[17 August 2019 17:26:38 by guest ]
WE [29 July 2019 12:24:55 by Sasha Fokin ] We network here..
WE [29 July 2019 12:24:04 by Sasha Fokin ] We network here..
WE [29 July 2019 12:22:50 by Sasha Fokin ]
sss [24 July 2019 16:33:40 by guest ]
gene_network__400_genes_1506_links [19 July 2019 14:15:43 by guest ]
gene_network__400_genes_1506_links [19 July 2019 14:11:15 by guest ]
tt22_6 [19 July 2019 13:35:13 by guest ]
tt22_4 [19 July 2019 13:22:35 by guest ]
tt22_3 [18 July 2019 21:34:52 by guest ]
tt22_1 [18 July 2019 21:08:43 by guest ]
tt1 [18 July 2019 19:14:36 by guest ]
mirnanet [08 July 2019 14:00:59 by guest ]
RELA [29 June 2019 12:36:02 by guest ]
lncRNA_reg_test1 [23 June 2019 15:29:15 by guest ]
HOTAIR, MALAT1, XIST lncRNA, long non-coding RNAs [22 June 2019 20:43:38 by guest ]
lncRNA_miR_sub1 [22 June 2019 13:29:50 by guest ]
mir199a2 [12 June 2019 18:55:58 by guest ]
mir199a2 [12 June 2019 18:54:07 by guest ]
mir29 [12 June 2019 17:29:19 by guest ]
breast cancer [29 May 2019 19:10:29 by guest ] breast cancer
Tongue Tumor 29 Selected mRna [29 May 2019 18:16:41 by guest ]
filters test [28 May 2019 23:13:29 by Sasha Fokin ]
filters test [28 May 2019 23:13:23 by Sasha Fokin ]

All saved networks




Coming soon:


Metabolites

Pubmeds

Drugs

Interactions

Mutations

Educational game